Make An Appointment
For emergency Case
|Monday – Friday||–||8:00 – 20:00|
|Saturday||–||8:00 – 17:00|
|Sunday||–||8:00 – 17:00|
Booking A visit
Get to Know All About Stem Cell Therapy for Cancer Using Dendritic Cells
Cancer, which is still a leading cause of death in the world, is a disease where cells in a certain area of the body expand and multiply uncontrollably. Cancerous cells, like tissues, can invade and kill adjacent healthy tissue. In one region of the body, it often starts before spreading to other regions, a phenomenon is known as metastasis. Toxic agents, radiation, genetic defects etc. may be the causative variables. The disorder becomes full blown as the causes producing the cancer cells are disproportionately strong against the immune system.
Dendritic Cells, what are they? Efficient antigen presenting cells that form an essential part of the immune system are dendritic cells (DCs). The only cells in our body that have the potential to cause a primary immune response are these cells. Owing to their crucial role in anti-cancer host responses, they have attracted scientific and clinical attention.
Do you Know About Cancer Using Dendritic Cells?
Dendritic cells (DCs) are a complex group of antigen-presenting specialized cells with important functions in activating and controlling innate and adaptive immune responses.
As such, there is currently a great deal of interest in modulating the DC feature to enhance immunotherapy for cancer.
Several strategies for targeting cancer DCs have been developed, such as the administration of immunomodulator antigens that mobilize and activate endogenous DCs, as well as the generation of DC-based vaccines.
Improved cancer therapies could lead to a greater understanding of the diversity and roles of DC subsets and how they are formed by the tumour microenvironment.
Here we would explain how numerous DC subsets in cancer settings impact immunity and resistance and address the repercussions for both existing cancer therapies and innovative immunotherapy strategies.
Symptoms of Cancer Using Dendritic Cells
The symptoms of Cancer Using Dendritic Cells tend to be different in patients who are suffering from this condition. There are some general symptoms of this condition that is given as follows:
- Dendritic cells (DC) constitute a heterogeneous group of innate immune cells that invade and process tumors and present naïve T cells with tumor-derived antigens.
- DC plays a crucial role in initiating the immunity of anti-tumor T cells and is thus a key therapeutic target for cancer immunotherapy.
- Suppressive signals present in the tumor microenvironment can inhibit the anti-tumor activity of DC.
- Issues in nonverbal communication like gestures and facial expressions
- In addition, DC with immunosuppressive activity, eliciting T cell tolerance and progressive tumor formation, can be recruited to tumors.
Get Stem Cell Therapy for Cancer Using Dendritic Cells
Since 2010, dendritic cell therapy has been used in medicine. Since then, over 4,500 persons have experienced it. In the treatment of breast cancer, lung cancer, sarcoma, melanoma, glioma and other tumors, it is used successfully. The physician removes the requisite cells from human blood during the procedure. They are manipulated in a sophisticated lab, which helps them to target the malignancy of the patient. The dendritic cells are then inserted in the form of a special vaccine into the human body. Like other immune therapy, DCT is not used as an independent treatment tool. It is recommended by physicians along with a course of chemotherapy, radiotherapy or multiple immune therapies. For certain forms of cancer, the cumulative effect of multiple medications greatly improves the efficacy of therapy by 2-3 times. Dendritic cell vaccination (DCV) is readily accepted by patients when opposed to other types of combination immunotherapy and does not induce side effects.
How Global Stem Cell Care Therapy Works ?
The Dendritic Cell cancer therapy treatment takes advantage of the dendritic cell’s regular function as an immune instructor.
This cells are normally found in the bloodstream of a human and are a cell of the blood.
Their normal purpose is to recognize, process and provide an immune response to a foreign material, like cancer cells, by bringing foreign substances to the attention of the rest of the immune system (mostly T lymphocyte cells).
The activated immune system is then able to circulate and kill the foreign particles in the body. In cancer, however, the immune system also fails. DC maturation and differentiation are impaired by the tumors and cause a generalized host inability to mount an efficient anti-tumor response.
Our protocol focuses on artificially improving and systemically transfusing dendritic cells that better attack antigens (cancer cells) and are capable of staging an immune response.
What to Expect from Stem Cell Treatment for Cancer Using Dendritic Cells?
In the field of cancer treatment, dendritic cells are used and promise some advantage of a normal function in the case of dendritic cells as an immune receptive cell. The cells are found in the bloodstream of a human, and they therefore count as a blood constituent. The purpose for which they are responsible is to recognise the foreign cells present and the body’s foreign objects.
It contains cancer cells that process them and put the immune response to rest by taking the foreign compounds to the rest of the immune system to attack them. The T lymphocyte cells are mainly affected by this. One of the most modified and widely used therapies is stem cell therapy for cancer using dendritic cells.
Cancer cells normally cause the body’s immune system to collapse. With the aid of stem cell therapy in India, the field of stem cell treatment has witnessed rapid progress. With the highest standard of patient process, Global Stem Cell Care is all about the latest treatment and technique prowess. Global Stem Cell Treatment is a program that expands medical tourism to people all around the world. The key and major reason for the introduction of more respectable and talented treatment facilities has been the growth of India in the field of healthcare. The care of stem cells is expanded into the best and most superlative procedure and treatment center.
Dendritic cells are the correct path to cancer treatment and often take full advantage of the ordinary and natural function that the dendritic cell, the immune trainer, is responsible for playing. The protocol that needs to be worked on is the explanation for developing the experience of artificially transfusing the cells into a more structured approach to the entire dendritic cells.
One of the largest and most trusted medical tourism service centres available, Global Stem Cell Care guarantees that the best healthcare centre is delivered by the most known and reliable doctors and hospitals. The therapy of stem cells is the safest and most effective and widely popular treatment that is managed and carried out by renowned doctors and surgeons. The best hospitals and reputed doctors deliver medical tourism. The best option available for people all over the world suffering from cancer is stem cell treatment for cancer using dendritic cells.
VIP Treatment to Patients at Global Stem Cell Care
- The therapy sessions given to the patients at Global Stem Cell Care occur in the VIP treatment room in the advanced clinic.
- 24*7 supervision is maintained on the patients by the efficient medical team.
- Global Stem Cell Care highly recommends the patients stay for a minimum of 3 days in Hospital.
Global Stem Cell care Treatment Procedure
The treatments that take place in Global Stem Cell Care are of 3 days. The treatment protocol is safe and non-invasive. The patients can travel the next day. The following is the day-wise schedule for the patients.
- Pick up from the Airport to the Hospital
- Interaction between Dr and Patient, to clear all their doubts at that time
- Admission procedure
- Clinical examination & Lab test will be done prescribed by the doctor
- Supportive Therapy
- Stem cell Procedure
- Supportive therapies
- Supportive Therapy
- Discharging formalities
- Drop back to the Airport
- For Admission, carry the identity card (Passport/ Pan Card / Driving License)
- Carry the hard copy of Patient reports
Early clinical trials investigating vaccination with tumor antigens pulsed with ex-vivo generated dendritic cells (DCs) provide evidence of the theory that therapeutic immunity can be elicited. However, in patients with stage IV cancer, the therapeutic advantage calculated by regression of existing tumors has been reported in just a fraction of patients. The next generation of DC vaccines is expected to produce large numbers of CD8+ T cells with a high avidity effector and to resolve regulatory T cells and tumor-developed suppressive conditions, a major obstacle in metastatic disease.
- Use of dendritic cell therapy in combination with other immune therapy to treat melanoma with metastases.
- Use of dendritic cell therapy, pneumococcal vaccine and radiotherapy to treat inoperable liver cancer.
- Use of dendritic cell therapy and immunotherapy after cryotherapy to treat inoperable melanoma.
- Use of dendritic cell therapy after bone marrow transplantation in the treatment of multiple myeloma.
Global Stem Cell Care in India offers the best and the most reliable stem cell treatment for various chronic diseases. 24/7 experienced staff offers the best treatment for the patients.
- Intravenous administration
- Liberation angioplasty
- Intrathecal (lumber puncture)
- Surgical administration for stroke
The following is the structure that is followed during the implantation stage:
The principal part of the vaccine is dendritic cells. Precursor cells are derived from the blood of the recipient. They can find, recognise and ingest pathogens. One of the most important defensive agents is dendritic cells in the human body. They find themselves in the blood, the flesh, the mucous membranes. Dendritic cells are among the first to activate a protective response once a pathogenic agent occurs in the body, be it a bacteria, a virus or a cancer cell. In many ways, dendritic cells can defend the body. Next, by drawing other protective cells to the source of infection or the process of disease, they activate the immune system. Secondly, “special forces” and “infantry” in human immunity play a vital role in the development of T- and B cells. The dendritic cell “teaches” the body to recognise and attack cells that present a health danger by consuming the pathogenic agent. This stimulates a global immunity process by which the body can resolve the infection on its own entirely. Cancer can withstand such defense, though. A comparison of peripheral blood and tissue is obtained. For analysis, the sample is sent to our laboratory. The collected Dendritic Cells are sent to the hospital, where the patient is admitted for transfusion, after processing for the specified number of days. Intravenously, the processed cells are delivered, after which the patient must remain under care in the hospital for a few hours.
The method of developing a vaccine for dendritic cells
- The doctor removes from the patient a blood sample and some cancer tissue.
- From the blood, immature precursor cells are chosen. They are grown in the laboratory with the assistance of special procedures.
- The dendritic cells that are produced are positioned in the same setting as cancerous tissues. They learn to know precisely the same type of cancer suffered by the patient.
- The vaccine is ready for 2-3 weeks after the blood is removed. To battle the tumour, dendritic cells activate the immune system.
Follow Up Follow Up
The most important phase in which doctors assess the health of the patient is follow-up. The Cancer Using Dendritic Cells treatment will not be done without follow-up. According to the doctor’s recommendation, the patient has to come and visit.
Frequently Asked Questions
A cancer vaccine made from your own blood can be identified as Dendritic Cell Therapy. Your dendritic cells are conditioned and replicated in the laboratory to reveal your unique cancer to your immune system. By focusing the dendritic cells of your body on correctly recognizing the cancer of your body as a threat, then reintroducing those cells into your system, the ‘qualified’ cells will enhance the potential of your body to function against the cancer. The idea is to have the patient’s specific cancer battled by their own enhanced or boosted self-immunity—a tailored cancer treatment vaccine!
In the bloodstream, dendritic cells are located and are responsible for detecting threats to which the immune system of the body needs to respond. Dendritic cells act as antigen presenters for the immune system when cancer grows in the body, eventually rendering cancer visible to the killer cells. These immune cells then invade the cancer which contribute to the death of cancer cells. The ‘trained’ cells will enhance the ability of your body to function against cancer by focusing the dendritic cells of your body, sensitizing them to your individual cancer, and then reintroducing those cells into your system. The aim is to fight your individual cancer with your own enhanced or strengthened self-immunity, a personalized vaccine for cancer care. Some supporting treatments are added to improve cancer awareness, such as Geographic Hyperthermia.
- A clear blood draw is done.
- Monocyte cells are washed out in the laboratory and exposed to different growth factors to convert into dendritic cells.
- By being exposed to particular cancer antigens, the dendritic cells are then “primed.”
- Qualified and concentrated dendritic cells will be given back to the patient by a quick injection or infusion after 7 days in the laboratory.
- Cytotoxic T-cells are activated and bound to cancer cells, allowing them to die (apoptosis).